Eclipsebio eRibo Pro Service
Eclipsebio has launched its eRibo Pro service to identify differential transcription and translation as well as high-resolution mapping of ribosome positioning. Customers receive an interactive report with two data sets from a single sample: a ribosome-protected fragment library and an RNA-seq library. These data are intended to enable researchers to, for instance, quantify changes in transcription and translation in response to therapeutics, the San Diego-based company notes on its website. eRibo Pro incorporates exclusively licensed Ribo-seq technology developed by researchers at the University of California, San Francisco, the company noted.